MANTENGOLI, ELISABETTA

MANTENGOLI, ELISABETTA  

Scienze della Salute (DSS)  

Mostra records
Risultati 1 - 20 di 35 (tempo di esecuzione: 0.032 secondi).
Titolo Data di pubblicazione Autore(i) File
A novel tetrabranched antimicrobial peptide which neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo 2009 Pini A.; Falciani C.; Mantengoli E.; Bindi S.; Brunetti J.; Iozzi S.; Rossolini G.M.; Bracci L.
A Questionnaire Integrated with the Digital Medical Record Improved the Coverage of a Control Program for Congenital Chagas Disease in Tuscany, Italy 2023 Anna Barbiero, Martina Mazzi, Antonia Mantella, Michele Trotta, Gian Maria Rossolini, Alberto Antonelli, Patrizia Bordonaro, Maria Grazia Colao, Anna Rosa Speciale, Tullio Di Benedetto, Mariarosaria Di Tommaso, Elisabetta Mantengoli, Felice Petraglia, Luisa Galli, Marco Pezzati, Carlo Dani, Maria José Caldes Pinilla, Cecilia Berni, Bassam Dannaoui, Pedro Albajar Viñas , Alessandro Bartoloni, Lorenzo Zammarchi
Antibiotic usage and risk of colonization and infection with antibiotic-resistant bacteria: a hospital population-based study 2009 Evelina Tacconelli; Giulia De Angelis; Maria Adriana Cataldo; Elisabetta Mantengoli; Teresa Spanu; Angelo Pan; Giampaolo Corti; Anna Radice; Lucia Stolzuoli; Spinello Antinori; Franco Paradisi; Giampiero Carosi; Roberto Bernabei; Massimo Antonelli; Giovanni Fadda; Gian Maria Rossolini; Roberto Cauda
Antimicrobial resistance in Europe and its potential impact on empirical therapy 2008 Rossolini G.M.; Mantengoli E.
Antipneumococcal activity of ulifloxacin compared to levofloxacin and ciprofloxacin 2011 Pallecchi L.; Riccobono E.; Montagnani F.; Di Maggio T.; Mantengoli E.; Pollini S.; Rossolini G.M.
Arbo-score: A rapid score for early identification of patients with imported arbovirosis caused by Dengue, Chikungunya and zika virus 2020 Vellere I.; Lagi F.; Spinicci M.; Mantella A.; Mantengoli E.; Corti G.; Colao M.G.; Gobbi F.; Rossolini G.M.; Bartoloni A.; Zammarchi L.
Cell-mediated and humoral adaptive immune responses to SARS-CoV-2 are lower in asymptomatic than symptomatic COVID-19 patients 2020 Mazzoni, Alessio; Maggi, Laura; Capone, Manuela; Spinicci, Michele; Salvati, Lorenzo; Colao, Maria Grazia; Vanni, Anna; Kiros, Seble Tekle; Mencarini, Jessica; Zammarchi, Lorenzo; Mantengoli, Elisabetta; Menicacci, Lorenzo; Caldini, Eleonora; Romagnani, Sergio; Liotta, Francesco; Morettini, Alessandro; Rossolini, Gian Maria; Bartoloni, Alessandro; Cosmi, Lorenzo; Annunziato, Francesco
Cellulitis caused by a methicillin-sensitive Staphylococcus aureus isolate harboring Panton-Valentine toxin in an American soldier returning from Iraq 2011 Tascini C.; Tagliaferri E.; Rossolini G.M.; Mantengoli E.; Mirarchi G.; Leonildi A.; Polidori M.; Menichetti F.
Characterization of Tn5393d, a complex Tn5393 Derivative Carrying the PER-1 Extended-Spectrum beta-Lactamase Gene and Other Resistance Determinants 2005 Mantengoli E.; Rossolini G.M.
Double Synergy Differential Test (DSDT) for detection of plasmid mediated AmpC-type beta-lactamases in Proteus mirabilis 2010 Sabia C.; Sarti M.; Mantengoli E.; Gargiulo R.; Mugnaioli C.; Rossolini G.M.
Dynamics of a nosocomial outbreak of multidrug-resistant Pseudomonas aeruginosa producing the PER-1 extended-spectrum beta-lactamase 2001 Luzzaro F.; Mantengoli E.; Perilli M.; Lombardi G.; Orlandi V.; Orsatti A.; Amicosante G.; Rossolini G.M.; Toniolo A.
Epidemiology and clinical relevance of microbial resistance determinants versus anti-Gram-positive agents 2010 Rossolini G.M.; Mantengoli E.; Montagnani F.; Pollini S.
Epidemiology and genetic characteristics of extended-spectrum beta-lactamase-producing Gram-negative bacteria causing urinary tract infections in long-term care facilities 2012 Marco Tinelli; Maria Adriana Cataldo; Elisabetta Mantengoli; Chiara Cadeddu; Ettore Cunietti; Francesco Luzzaro; Gian Maria Rossolini; Evelina Tacconelli
Epidemiology and genetic characteristics of extended-spectrum β-lactamase-producing gram-negative bacteria causing urinary tract infections in long-term care facilities 2012 Tinelli, Marco; Cataldo, Maria Adriana; Mantengoli, Elisabetta; Cadeddu, Chiara; Cunietti, Ettore; Luzzaro, Francesco; Rossolini, Gian Maria; Tacconelli, Evelina
Epidemiology of infections caused by multiresistant Gram-negatives: ESBLs, MBLs, panresistant strains 2007 Rossolini G.M.; Mantengoli E.; Docquier J.D.; Musmanno R.A.; Coratza G.
Escherichia coli ST131 producing extended-spectrum β-lactamases plus VIM-1 carbapenemase: further narrowing of treatment options 2011 E.Mantengoli; F.Luzzaro; P.Pecile; D.Cecconi; A.Cavallo; L.Attala; A.Bartoloni; G.M.Rossolini
Evaluation of candidemia and antifungal consumption in a large tertiary care Italian hospital over a 12-year period 2018 Mencarini, Jessica; Mantengoli, Elisabetta; Tofani, Lorenzo; Riccobono, Eleonora; Fornaini, Rossella; Bartalesi, Filippo; Corti, Giampaolo; Farese, Alberto; Pecile, Patrizia; Boni, Luca; Rossolini, Gian Maria; Bartoloni, Alessandro
First-dose mRNA vaccination is sufficient to reactivate immunological memory to SARS-CoV-2 in subjects who have recovered from COVID-19 2021 Mazzoni A.; Lauria N.D.; Maggi L.; Salvati L.; Vanni A.; Capone M.; Lamacchia G.; Mantengoli E.; Spinicci M.; Zammarchi L.; Kiros S.T.; Rocca A.; Lagi F.; Colao M.G.; Parronchi P.; Scaletti C.; Turco L.; Liotta F.; Rossolini G.M.; Cosmi L.; Bartoloni A.; Annunziato F.
In vitro synergism of ulifloxacin plus piperacillin/tazobactam against clinical isolates of Enterobacteriaceae producing extended-spectrum or AmpC-type beta-lactamases 2010 Tascini C.; Mantengoli E.; Geminiani G.; Leonildi A.; Di Maggio T.; Fondelli S.; Rossolini G.M.; Tagliaferri E.; Menichetti F.
Information technology systems to support antimicrobial stewardship programs 2022 Gallinoro, V; Grazzini, M; Paolini, D; Dannaoui, B; Farese, A; Mantengoli, E; Ipponi, A; Pieralli, F; Bonaccorsi, G; Niccolini, F